Temasek Life Sciences Private Ltd's Net Worth
$80 Million
Who is Temasek Life Sciences Private Ltd?
Temasek Life Sciences Private Ltd has an estimated net worth of $80 Million. This is based on reported shares across multiple companies, which include Guardant Health, Inc., Intellia Therapeutics, Inc., Pear Therapeutics, Inc., Coherus BioSciences, Inc., Vir Biotechnology, Inc., VICAL INC, Homology Medicines, Inc., and Akili, Inc..
SEC CIK
Temasek Life Sciences Private Ltd's CIK is 0001379349
Past Insider Trading and Trends
2018 was Temasek Life Sciences Private Ltd's most active year for acquiring shares with 5 total transactions. Temasek Life Sciences Private Ltd's most active month to acquire stocks was the month of September. 2009 was Temasek Life Sciences Private Ltd's most active year for disposing of shares, totalling 44 transactions. Temasek Life Sciences Private Ltd's most active month to dispose stocks was the month of April. 2019 saw Temasek Life Sciences Private Ltd paying a total of $10,000,000.00 for 5,499,999 shares, this is the most they've acquired in one year. In 2009 Temasek Life Sciences Private Ltd cashed out on 944,655 shares for a total of $2,254,224.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Guardant Health, Inc. (GH) Snapshot price: $22.185
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.61M |
—
|
—
| 1.61M |
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +161.16% | 790.53K |
$18.00 | $5,400,000.00 | 1.28M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pear Therapeutics, Inc. (PEARQ) Snapshot price: $0.0067
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coherus BioSciences, Inc. (CHRS) Snapshot price: $2.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) Snapshot price: $9.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.5M |
$20.00 |
—
| 5.5M |
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||